• Beleodaq (Belinostat)

    Beleodaq (Belinostat)

    Peripheral T-Cell Lymphoma Treatment with Beleodaq (Belinostat) This type of cancer, accounts for over 15% of all non-Hodgkin’s lymphoma cases in the United States of America. Peripheral T- cell lymphoma develops when the T- lymphocytes (white blood cells) becomes abnormal or develops abnormally. There are different treatment methods that can be used for this condition.